Literature DB >> 20134444

New vaccine tailored to the weakened elderly immune system.

Charlotte Schubert.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20134444     DOI： 10.1038/nm0210-137a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

Authors:  Ann R Falsey; John J Treanor; Nadia Tornieporth; Jose Capellan; Geoffrey J Gorse
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

2.  The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.

Authors:  T M Govaert; C T Thijs; N Masurel; M J Sprenger; G J Dinant; J A Knottnerus
Journal:  JAMA       Date:  1994-12-07       Impact factor: 56.272

3.  Influenza vaccination and mortality: differentiating vaccine effects from bias.

Authors:  Bruce Fireman; Janelle Lee; Ned Lewis; Oliver Bembom; Mark van der Laan; Roger Baxter
Journal:  Am J Epidemiol       Date:  2009-07-22       Impact factor: 4.897
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.